Capital World Investors
MNTA

Capital World Investors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Capital World Investors’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,155,000
Closed -$17.1M – 529
2015
Q4 		$17.1M Buy
1,155,000
+115,000
+11% +$1.92M ﹤0.01% 435
2015
Q3 		$17.1M Hold
1,040,000
– – 0.01% 440
2015
Q2 		$23.7M Buy
+1,040,000
New +$20.7M 0.01% 423

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors's MNTA Position: Q1 2016 in Review

Capital World Investors sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q1 2016, closing a stake of 1,155,000 shares — an estimated $17.1M sold.

Capital World Investors first reported a position in MNTA in Q2 2015 and held it in 3 quarters. The position peaked at $23.7M in Q2 2015. 148 funds tracked by Wall St. Rank hold MNTA as of Q1 2016.

  • Capital World Investors reported no remaining Momenta Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
  • Capital World Investors sold 1,155,000 Momenta Pharmaceuticals, Inc. shares in Q1 2016, an estimated $17.1M.
  • Capital World Investors first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2015 and held it in 3 quarters.
  • Capital World Investors's Momenta Pharmaceuticals, Inc. position peaked at $23.7M in Q2 2015.
  • 148 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q1 2016.

Based on Capital World Investors's 13F filing for Q1 2016, filed 16 May 2016.